VENN Skincare, Inc. Files International Patent For Solubilizatio

VENN Skincare, Inc. Files International Patent For Solubilization Technology

Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact

SOURCE VENN Skincare, Inc.

For the first time, Ginsenoside Compound K is used effectively in skincare

SAN FRANCISCO, March 8, 2018 /PRNewswire/ -- Since its launch in November of 2017, VENN Skincare, Inc. has revolutionized the skincare industry with an effective all-in-one formula featuring advanced technology, powerhouse ingredients, and clinically-tested results. Based on over 20 years of research, VENN Skincare, Inc. is proud to announce the filing of an international patent for its groundbreaking technology: Solubilization Technology-the water solubilization of Ginsenoside Compound K, which is one of main bioactive components of ginseng that is obtained from bio-conversion of ginseng saponin using microorganism fermentation.

VENN Skincare, Inc. (PRNewsfoto/VENN Skincare, Inc.)

Compound K is known to deliver powerful, anti-aging benefits, including: fighting active oxygen and free radicals, promoting collagen synthesis and elastase inhibition, reducing the appearance of wrinkles, and improving skin elasticity and firmness.

Until now, this potent ingredient was unable to be effectively used in skincare formulas and absorbed into the skin due to its extremely low solubility and hydrophobic properties. With its solubilization technology, VENN is able to dissolve Compound K into a water-solubilized mixture containing high concentrations of Compound K, and thereby create skincare formulas with Compound K as a key ingredient that can be effectively absorbed by skin and deliver powerful, anti-aging benefits to skin.  Compound K is, therefore, one of the key ingredients in VENN's hero product, Age-Reversing All-In-One Concentrate.

"Being able to incorporate Compound K into our skincare formulas truly sets VENN apart in the marketplace," said Brian Oh, CEO and Founder of VENN Skincare. "Our solubilization technology, which is one of the three key technologies that constitute VENN's proprietary Concentric Technology™, allows us to bring to consumers Compound K and many other natural ingredients that are very difficult to use effectively in skincare formulas due to their low solubility."

Delivering anti-aging benefits in a single step, VENN's all-in-one concentrate eliminates the need for numerous products, including toners, serums, ampoules, creams, and oils. With the filing of an international patent for the solubilization technology, VENN's clinically-tested formula harnessing this technology with natural key ingredients and bioactives will be proprietary and completely unique to the category.

VENN Age-Reversing All-In-One Concentrate is available at for $185.

About VENN Skincare, Inc.
Brian Oh, a NYC and Silicon Valley lawyer with a deep passion for skincare, set out on a mission to find a safe and effective regimen that met his demanding lifestyle. An avid user of premium products, Brian found the beauty counter cluttered with bottles of serums, ampoules, creams, oils, and more, that all claimed different results, and multiple steps that he could not devote daily time to. Brian set out to change the industry and introduce a new category that would meet the needs of a modern lifestyle-anti-aging, all-in-one skincare that not only streamlines routines, but is just as, if not more, effective than other high-end products on the market.

Media contact: Katie Heelon;


Cision View original content with multimedia:

©2017 PR Newswire. All Rights Reserved.

Powered by Frankly